e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Cutting edge: drug delivery to the airways
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exogenous administration of bone marrow-derived stem cells in experimental COPD
B. Lobo, R. Puig-Pey, E. Ferrer, D. Domínguez-Fandos, N. Coll, J. García, C. Bonjoch, J. A. Barberà, V. I. Peinado (Barcelona, Spain)
Source:
Annual Congress 2013 –Cutting edge: drug delivery to the airways
Session:
Cutting edge: drug delivery to the airways
Session type:
Oral Presentation
Number:
225
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Lobo, R. Puig-Pey, E. Ferrer, D. Domínguez-Fandos, N. Coll, J. García, C. Bonjoch, J. A. Barberà, V. I. Peinado (Barcelona, Spain). Exogenous administration of bone marrow-derived stem cells in experimental COPD. Eur Respir J 2013; 42: Suppl. 57, 225
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Bone marrow-derived mesenchymal stem cells transplantation in a model of bronchiolitis obliterans
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Bone marrow-derived MSCs from patients with COPD have abnormal functional capacity
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Intratracheal administration of bone marrow-derived mesenchymal stem cells ameliorates lung function
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Effect of low level laser (LLL) and mesenchymal stem cells (htMSCs) therapies on cigarette-induced lung inflammation in mice
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Impaired migration of bone marrow mesenchymal stem cells in COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
In vivo
chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Late-breaking abstract: Comparison of bone marrow derived-mononuclear cells with mesenchymal stem cells on inflammatory and remodeling processes in experimental chronic allergic asthma
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Year: 2011
Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Functional comparison of bone-marrow derived mesenchymal stromal cells obtained from COPD patients and non-COPD controls
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
The effect of allergen-pulsed bone marrow-derived dendritic cells in mouse asthma model depends on the injection time
Source: Annual Congress 2004 - Animal models of allergic airway disease
Year: 2004
Effect of intratracheal transplantation of bone marrow-derived endothelial progenitor cell on cigarette smoking-induced emphysema in mice
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Allergen-pulsed bone marrow-derived dendritic cells abolish the influx of allergic inflammatory cells in mouse asthma model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept